UNSPSC 51392902: Azanator

This classification denotes a bronchodilator with the molecular formula C18H18N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 699725286I chemically known as 5-(1-methyl-4-piperidylidene)-5h-(1)benzopyrano(2,3-b)pyridine but generally known as azanator, which bears US NIH Compound Identifier 38298. European Medicines Agency schedules Azanator in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05634MIG.

UNSPSC 51392902 Azanator, a Commodity code, covers naloxone and drug deactivation systems that state and local health and human services agencies procure to support community health and overdose-response initiatives. Recent solicitations show state and local governments purchasing these products in operational quantities—Seminole County, Florida is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for distribution through county health facilities. The code encompasses both the active pharmaceutical product and the associated deactivation or disposal systems, which agencies source through competitive bidding processes to support public health emergency response and community health programming.

Issuing bodies under this code include county health departments and state health and human services agencies. Seminole County, Florida solicited naloxone and deactivation systems through an IFB (Solicitation IFB60459723LAS, due July 26, 2023) with annual procurement quantities and quarterly delivery schedules. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription and pharmaceutical supply models, which suggests state-level interest in broader pharmacy benefit sourcing strategies that may encompass products in this code's scope. Recent activity is concentrated in the Southeast (Florida) and Texas, though the Texas RFI indicates emerging state-level procurement interest. The Seminole County solicitation demonstrates the operational procurement pattern: fixed annual quantities, quarterly delivery cycles to designated health facilities, inclusion of shipping costs in vendor pricing, and standard compliance requirements including E-Verify and drug-free workplace certification.